Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 10 July 2017, 11:38 HKT/SGT
Share:
    

Source: NEC Corporation
NEC Joins Hyperledger to Advance Blockchain Technology

TOKYO, July 10, 2017 - (JCN Newswire) - NEC Corporation (TSE: 6701) announced that it has joined Hyperledger as a Premier member, emphasizing NEC's commitment to leverage its innovative research to both advance blockchain technology as well as its global adoption.

Hyperledger is an open source collaborative effort created to advance blockchain technologies and services around the globe by addressing important features for a cross-industry open standard for distributed ledgers.

Recent years have seen an increasing focus on devising novel secure and scalable blockchain platforms that address the needs of many industrial use cases. NEC has been leading academic research on blockchain security since the introduction of the Bitcoin system.

In December 2016, NEC Laboratories Europe released, together with Aalto University, a novel blockchain consensus technology based on Byzantine fault tolerant protocols. This technology builds on hardware-based trusted execution environments and combines their use with lightweight secret sharing. NEC's technology can achieve a throughput over 100,000 transactions per second - making it the world's fastest and most scalable Byzantine fault tolerant protocols to date.

"NEC's global reach will be a huge asset, as we continue to grow the commercial ecosystem for Hyperledger technologies," said Brian Behlendorf, Hyperledger Executive Director. "We welcome NEC and look forward to collaborating with them to help develop an open, distributed ledger technology that makes business processes transparent and solves interoperability across many industries."

"NEC is promoting the transformative benefits of blockchain technology and advancing its adoption by contributing our expertise and knowledge to the Hyperledger community," said Dr. Juergen Quittek, Vice President at NEC Laboratories Europe.


Contact:
NEC 
Seiichiro Toda         
s-toda@cj.jp.nec.com 
+81-3-3798-6511


Topic: Press release summary
Source: NEC Corporation

Sectors: Cloud & Enterprise
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


NEC Corporation Links

http://www.nec.com

https://www.facebook.com/nec.global/

https://twitter.com/NEC_corp

https://www.youtube.com/user/NECglobalOfficial

https://www.linkedin.com/company/nec/

NEC Corporation
Apr 11, 2024 14:10 HKT/SGT
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
Apr 10, 2024 12:36 HKT/SGT
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Apr 8, 2024 12:45 HKT/SGT
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines
Mar 25, 2024 09:08 HKT/SGT
NEC develops marketing strategy planning & effectiveness simulation technology using generative AI
Mar 22, 2024 07:38 HKT/SGT
NEC and NTT successfully conduct first-of-its-kind long-distance transmission experiment over 7,000km using 12-core optical fiber
Mar 21, 2024 09:02 HKT/SGT
NEC and Tokyo Medical and Dental University use AI to assist self-care for chronic lower back pain
Mar 20, 2024 14:30 HKT/SGT
NEC and Skyloom to Pioneer 100 Gbps Space Optical Communications, Transforming Global Internet Connectivity
Mar 7, 2024 10:24 HKT/SGT
NEC named to list of Top 100 Global Innovators by Clarivate for 13th consecutive year
Mar 5, 2024 08:05 HKT/SGT
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
Mar 4, 2024 10:11 HKT/SGT
NEC and Sumitomo Corporation Sign Strategic Partnership Agreement to Expand Global Sales of the CropScope Agricultural ICT Platform
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: